Tag: anjali advani

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

ash16_650x450
December 5, 2016/Research

Vadastuximab for AML: Investigator Predicts Changes to Standard Therapy in Near Future

Drug targets CD33 to produce high remission rates

Advani_650x450-photo-credit
July 20, 2016/Blood Cancers

Novel Agent Holds Promise for Refractory/Relapsed ALL

Phase 3 results reported in NEJM

Dr.Advani_650x450
February 1, 2016/Blood Cancers

Evaluating Novel Therapies in Acute Leukemia

Promising clinical trials underway

ASH2014_690x380
December 15, 2014/Research

Treating Young Adults with Acute Lymphoblastic Leukemia

Superior outcome for young adults on pediatric regimen

advani_690x480
December 8, 2014/Research

Novel Antibody-Drug Conjugate Targets CD33-Positive AML

SGN-CD33A demonstrates encouraging antileukemic activity

BackPage 1 of 1Next
Advertisement
Ad